Submit Content
Get the latest delivered to your inbox
Privacy Policy

Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2012, the Group achieved net sales of USD 56.7 billion, while R&D throughout the Group amounted to approximately USD 9.3 billion (USD 9.1 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 129,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.

 

Novartis is on Twitter. Sign up to follow @Novartis at twitter.com/novartis.

    Novartis Releases 2015 Corporate Responsibility Performance Report Image

    POSTED 

    01-27-16

    Novartis Releases 2015 Corporate Responsibility Performance Report

    Novartis has published its 2015 Corporate Responsibility (CR) Performance Report. The report is based on the Global Reporting Initiative G4 guidelines, with disclosure at “comprehensive” level, making it the first comprehensive level-report in the healthc...

     Novartis Foundation and Partners Launch New Hypertension Program in Ghana Image

    POSTED 

    10-30-15

    Novartis Foundation and Partners Launch New Hypertension Program in Ghana

    The Novartis Foundation and its partners have begun screening patients in the Community-based Hypertension Improvement Project (ComHIP), a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management and control in Ghana.

    With the innovative...

    Novartis Foundation Presents Healthcare Models and Disease Elimination Programs at ECTMIH Image

    POSTED 

    09-07-15

    Novartis Foundation Presents Healthcare Models and Disease Elimination Programs at ECTMIH

    The Novartis Foundation and its partners will highlight progress towards transforming the health of the poorest populations at the 9th European Congress on Tropical Medicine and International Health (ECTMIH) held in Basel from September 6 – 10. Updates on nine Novartis...

    Sandoz Launches Breathe Africa Program to Improve Asthma Diagnosis, Treatment and Patient Outcomes in Zambia Image

    POSTED 

    07-24-15

    Sandoz Launches Breathe Africa Program to Improve Asthma Diagnosis, Treatment and Patient Outcomes in Zambia

    Sandoz today announced the launch of Breathe Africa, a respiratory health program aimed at improving the diagnosis and treatment of asthma through sharing medical expertise and donating medicines. The program will start in Zambia and will bring European doctors to work...

    Novartis Pharmaceuticals Corporation is First Company to Receive Number One Ranking Two Years in a Row on DiversityInc Top 50 Companies for Diversity List  Image

    POSTED 

    04-24-15

    Novartis Pharmaceuticals Corporation is First Company to Receive Number One Ranking Two Years in a Row on DiversityInc Top 50 Companies for Diversity List

    Novartis Pharmaceuticals Corporation (NPC) has been named the top company for diversity for the second year in a row on the annual DiversityInc Top 50 Companies for Diversity listing. DiversityInc announced the results of its 2015 Top 50 Companies for Diversity on April 23 at an awards...

    Sandoz Announces Training Program for Midwives in Ethiopia, to Reduce Maternal and Newborn Mortality  Image

    POSTED 

    03-03-15

    Sandoz Announces Training Program for Midwives in Ethiopia, to Reduce Maternal and Newborn Mortality

    Sandoz today announced the launch of a new program, New Life & New Hope, to improve maternal and child health and reduce mortality associated with childbirth. The program, ahead of International Women’s Day on March 8, kicks-off with the completion of the first in a series of Sando...

    Novartis Releases 2013 Corporate Responsibility Performance Report Using Best-in-class Reporting Standard, Increasing Transparency Image

    POSTED 

    07-09-14

    Novartis Releases 2013 Corporate Responsibility Performance Report Using Best-in-class Reporting Standard, Increasing Transparency

    Novartis has published a Corporate Responsibility (CR) Performance Report for 2013. The report reflects the best-in-class reporting standard, the Global Reporting Initiative’s (GRI) G4 guidelines, one year in advance of required implementation.

    “Our corporate responsibility wo...

    Sandoz Joins Forces With United Nations to Combat a Leading Cause of Child Mortality Worldwide Image

    POSTED 

    06-30-14

    Sandoz Joins Forces With United Nations to Combat a Leading Cause of Child Mortality Worldwide

    • Sandoz makes long-term commitment to support UN initiative on child mortality
    • Commitment to UN Every Newborn Action Plan involves development and supply of recommended WHO formulation for treating childhood pneumonia
    • Pneumonia is the leading cause of d...
    Novartis Foundation for Sustainable Development to Work with Netherlands Leprosy Relief to Help Reduce Leprosy Transmission Image

    POSTED 

    06-09-14

    Novartis Foundation for Sustainable Development to Work with Netherlands Leprosy Relief to Help Reduce Leprosy Transmission

    The Novartis Foundation for Sustainable Development and Netherlands Leprosy Relief (NLR) today announced their collaboration with national leprosy programs and other International Federation of Anti-Leprosy Associations (ILEP) partners to interrupt transmission of leprosy. In pilot sites of sever...

    Novartis and Malaria No More Provide Two Million Antimalarial Treatments to Children in Zambia Image

    POSTED 

    04-07-14

    Novartis and Malaria No More Provide Two Million Antimalarial Treatments to Children in Zambia

    Novartis announced today that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More’s Power of One campaign. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One...

    Novartis Logo

    Novartis

    Novartis

    Join today and get the latest delivered to your inbox